Citation

81 FR 22283

Multiple canonical documents share this first-page citation.

Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability Friday, April 15, 2016 81 FR 22283
Xanodyne Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 8 New Drug Applications and 46 Abbreviated New Drug Applications for Propoxyphene Products; Correction Friday, April 15, 2016 81 FR 22283